Intestinal Methanogen Overgrowth (IMO) More Prevalent than SIBO in Parkinson’s disease with Constipation: Preliminary Results
Objective: Our aim is to quantify the prevalence of small intestinal bacterial overgrowth (SIBO) and intestinal methanogen overgrowth (IMO) in PD subjects with constipation compared…The Presence of Efferent Brain-Gut Neuropathy Correlates with Severe Constipation in Parkinson’s disease
Objective: We aim to correlate brain-gut neuropathy amongst cortico- and lumbosacro-anorecal efferent pathways in PD subjects with severe constipation measured by prospective stool diary. Background:…Possible correlations between symptoms suggesting gastroparesis and dyskinesias in advanced Parkinson’s disease
Objective: The objective was to describe the spectrum of gastrointestinal complaints in a large cohort of patients with advanced Parkinson’s Disease (APD), who were repeatedly…Helicobacter pylori eradication in Parkinson’s disease: A double-blind randomized placebo-controlled study
Objective: To evaluate the effects of Helicobacter pylori eradication on PD symptoms. Background: Globally, H. pylori infection remains a common problem. Cross-sectional studies in Parkinson's disease (PD)…Gastrointestinal symptoms as a risk factor for the appearance of motor fluctuations in patients with advanced Parkinson disease
Objective: Gastrointestinal alterations in patients with Parkinson`s Disease (EP) provoke alterations in the absorption of levodopa that facilitates the development of motor fluctuations. Study the…Clostridium Difficile Infection and Risk of Parkinson’s Disease: A Swedish Population-Based Cohort Study
Objective: To examine whether individuals with a history of Clostridium difficile (C. diff) infection have an elevated risk of developing Parkinson’s disease (PD). Background: The…Antibiotic exposure and Risk for Parkinson’s Disease
Objective: To determine whether antibiotic exposure is associated with Parkinson's disease (PD). Background: Environmental exposures affect the risk of PD and it has been proposed…Outcomes of Percutaneous Endoscopic Gastrostomy (PEG) Feeding in Parkinson’s
Objective: To describe outcomes of PEG feeding in Parkinson's and related disorders. Background: PEG feeding provides a means of getting food, liquid and medication safely…Gastrointestinal symptoms predict cognitive decline in Parkinson’s Disease
Objective: To explore the predictive value of non-motor symptoms on the cognitive decline of patients with Parkinson’s disease (PD) in a three-year follow up. Background:…Comparison of Zonisamide with Non-Levodopa, Anti-Parkinson’s disease Drugs in the Incidence of Parkinson’s Disease-Relevant Symptoms
Objective: This study was to compare zonisamide and other anti-PD drugs by analyzing their associations with the incidence of PD-relevant symptoms. Background: Patients with Parkinson’s…
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 11
- Next Page »